Falsified antibiotics reported in WHO African Region

Falsified HEALMOXY (Amoxicillin) identified in Cameroon and Central African Republic
Falsified antibiotics reported in WHO African Region

On 23 April 2025, the World Health Organization issued a product alert falsified HEALMOXY (Amoxicillin) 500mg capsules identified in WHO African Region [1]. These falsified products have been identified in both Cameroon and Central African Republic but WHO have warned that other countries and regions may also be affected.

Amoxicillin is an antibiotic used to treat various bacterial infections. The affected batches of capsules, which have been shown not to contain the active ingredient (amoxicillin), are not effective in treating bacterial infections and therefore pose a risk to the general population, especially vulnerable individuals and those with severe infections.

Some of these falsified products displayed inconsistent dates on the packaging but otherwise looked very similar to the authentic packaging and products [2].

This incident highlights the ongoing issue worldwide with falsified drugs. It is estimated that around 10% of medical products in low- and middle-income countries are substandard or falsified [3].

Advice for travellers

Before you travel

  • Take adequate supplies of your usual medication away with you in original packaging
  • Be aware of the risks of falsified medical products; this term is used to describe deliberate misrepresentation of a drug or medical product (including 'substandard' or 'counterfeit')

While you are away

  • Always obtain medication from a trusted and licensed outlet
  • Examine any packaging for obvious spelling or grammatical errors
  • Ensure the medication looks correct and is not degraded or discoloured
  • Check manufacturing and expiration dates

When you return

  • If you required additional supplies of medication or started new medication, prescribed whilst abroad, you are advised to see your regular doctor on return
  • If you are unwell after travelling, you should seek advice from your GP or pharmacist and mention your recent travel

Advice for health professionals

Health care professionals should ensure travellers are made aware of the risk of falsified medication in many parts of the world. They should also be mindful of returning travellers who are unwell and may have received ineffective treatment whilst overseas.


Search by


Explore more

Marburg virus disease in Ethiopia

On 26 January 2026, the Ministry of Health of Ethiopia declared the end of the Marburg virus disease outbreak

Updated: 05 February 2026

ABTA Destinations to Watch report published

ABTA has launched its Destinations to Watch report for 2026

Updated: 03 February 2026

Mefloquine shortage

Shortage of 250mg mefloquine (Lariam) antimalarial tablets in the United Kingdom (UK) until the end of March 2026

Updated: 30 January 2026

NaTHNaC Telephone Advice Line for health professionals

Additional advice line sessions are planned, starting in January 2026

Updated: 21 January 2026

Country Information updates: Japanese encephalitis vaccine recommendations

NaTHNaC has reviewed and updated the Japanese encephalitis (JE) country-specific information and vaccine recommendations

Updated: 19 January 2026